Cardioprotection gain with apelin‐13: A matter of signalling

Publisher： John Wiley & Sons Inc

E-ISSN： 1748-1716|222|2|apha.13005-apha.13005

ISSN： 1748-1708

Source： ACTA PHYSIOLOGICA (ELECTRONIC), Vol.222, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Redox signalling and cardioprotection: translatability and mechanism

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 8, 2015-04 ,pp. : 1974-1995

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apelin‐13 treatment enhances the stability of atherosclerotic plaques

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apelin‐induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 222, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extracellular signalling molecules in the ischaemic/reperfused heart – druggable and translatable for cardioprotection?

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 8, 2015-04 ,pp. : 2010-2025

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2

By            

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 733-738

Spandidos Publications

Access to resources Recommend Favorite